Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

This study has been completed.
Shaheed Surhawardy Medical College and Hospital
International Centre for Diarrhoeal Disease Research, Bangladesh
Information provided by (Responsible Party):
Drugs for Neglected Diseases Identifier:
First received: May 11, 2010
Last updated: January 20, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)